Mixed
Sleeve gastrectomy (SG) combined with a left ventricular assist device (LVAD) serves as a feasible and effective pathway to cardiac transplantation in morbidly obese patients with end-stage heart failure.
If you have severe heart failure and are too heavy for a heart transplant, getting an LVAD (heart pump) and sleeve gastrectomy (stomach reduction) together is a viable medical pathway. This combination can significantly reduce your weight and make you eligible for a transplant, which was previously impossible due to your size. This requires specialized surgical care.
LVAD and SG constitute a feasible pathway to cardiac transplantation in morbidly obese patients with end-stage HF. LVAD permits temporary cardiac support, whereas SG assists in efficacious weight loss.
Why this rating
Small case series (n=3), retrospective review, no control group.
Source
Sleeve Gastrectomy and Left Ventricular Assist Device for Heart Transplant
J Greene et al. · JSLS Journal of the Society of Laparoscopic & Robotic Surgeons · 2017
DOI 10.4293/jsls.2017.00049
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →